Literature DB >> 10469187

CagA and VacA: virulence factors of Helicobacter pylori in Thai patients with gastroduodenal diseases.

V Mahachai1, P Tangkijvanich, N Wannachai, P Sumpathanukul, P Kullavanijaya.   

Abstract

BACKGROUND: The aim of this study was to assess the seroprevalence of cytotoxin-associated gene A (cagA) and vacuolating cytotoxin gene A (vacA) of Helicobacter pylori in selected Thai populations with specific gastroduodenal diseases.
MATERIALS AND METHODS: The immunoblot assay was used to detect serum antibodies against CagA and VacA obtained from the following patients: 87 cases of nonulcer dyspepsia (NUD), 61 cases of duodenal ulcer (DU), 49 cases of gastric ulcer (GU), and 10 cases of gastric cancer (GC).
RESULTS: Serum antibodies to CagA were detected in 75.4% of all patients (70. 1% of NUD, 78.7% of DU, 77.6% of GU, and 90% of GC). Although the prevalence of CagA seropositivity in GC patients was higher than in the other three groups, the difference was not statistically significant (p >.05).
CONCLUSIONS: The high seroprevalence of the CagA-positive H. pylori strain in patients with peptic ulcer, GC, and NUD indicates that this strain is common in Thai patients with gastroduodenal diseases. Furthermore, phenotypic classification of H. pylori into type 1 (CagA-positive, VacA-positive) and type 2 (CagA-negative, VacA-negative) is not a useful marker for screening patients with severe forms of gastroduodenal diseases.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10469187     DOI: 10.1046/j.1523-5378.1999.99305.x

Source DB:  PubMed          Journal:  Helicobacter        ISSN: 1083-4389            Impact factor:   5.753


  6 in total

1.  cagA and vacA status and influence of Helicobacter pylori infection on serum oxidative DNA damage in Iranian patients with peptic ulcer disease.

Authors:  Z Khodaii; S M H Ghaderian; R Akbarzadeh Najar; H Nejati; A S Tabatabaei Panah
Journal:  Ir J Med Sci       Date:  2010-08-20       Impact factor: 1.568

2.  Responses of endoscopy patients in Ladakh, India, to Helicobacter pylori whole-cell and Cag A antigens.

Authors:  Judith Romero-Gallo; Guillermo I Pérez-Pérez; Richard P Novick; Patrick Kamath; Tsering Norbu; Martin J Blaser
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

3.  Helicobacter pylori virulence factors in duodenal ulceration: A primary cause or a secondary infection causing chronicity.

Authors:  Frank I Tovey; Michael Hobsley; John Holton
Journal:  World J Gastroenterol       Date:  2006-01-07       Impact factor: 5.742

4.  Association of CagA and VacA presence with ulcer and non-ulcer dyspepsia in a Turkish population.

Authors:  Kantarceken Bulent; Aladag Murat; Atik Esin; Koksal Fatih; Harputluoglu MMMurat; Harputluoglu Hakan; Karincaoglu Melih; Ates Mehmet; Yildirim Bulent; Hilmioglu Fatih
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

5.  Comparison of cytotoxin genotypes of Helicobacter pylori in stomach and saliva.

Authors:  Jie Wang; David S Chi; John J Laffan; Chuanfu Li; Donald A Ferguson; Peter Litchfield; Eapen Thomas
Journal:  Dig Dis Sci       Date:  2002-08       Impact factor: 3.199

6.  Increased seropositivity of Helicobacter pylori cytotoxin-associated gene-A in Behçet's disease.

Authors:  Teoman Zafer Apan; Ragip Gürsel; Alp Dolgun
Journal:  Clin Rheumatol       Date:  2006-10-05       Impact factor: 3.650

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.